“Already now, the circular and sustainable bioeconomy is contributing to all dimensions and objectives of the European Green Deal. Through the substitution of fossil-based products and materials and through carbon sequestration in soil and forests, together with its storage in harvested wood products, the bioeconomy can generate significant carbon savings to reduce the EU’s greenhouse gas emissions by at least 55% by 2030”. To say this is a European Commission’s official, who prefers to remain anonymous. In this long interview with IlBioeconomista, the Commission’s official talk about the Green New Deal, the bioeconomy and the partnership Circular Bio-based Europe.
“The paradigm of the circular bioeconomy for Novamont means renerating territories, focusing on soil health and on the decarbonisation of the atmosphere”. To say it – in this interview with Il Bioeconomista – is Giulia Gregori, Strategic Planning and Corporate Communications Manager at Novamont, the company based in Novara, Italy, which is a leader in the world market of bioplastics. Gregori talks about the circular bioeconomy in the frame of the EU Green Deal and the circular economy action plan and talks also about Grace, the BBI JU demo project focused on hemp and miscanthus.
“In my opinion the bioeconomy is an important concept currently missing in the Green Deal, and it should be connected to the circular economy concept (a main pillar of the Green Deal).” Marc Palahí, Director at EFI (European Forest Institute), talks to Il Bioeconomista. In this exclusive interview, he talks about pandemic and Green New Deal, forests and the role of cities and regions in the development of the EU bioeconomy.
“At Union level, the European Green Deal is surely a clear and strong signal to many industries, and this will help our clients to gain further competing edges vs parties that still struggle to understand the benefit of implementing biosynthesis into their processes as tool to increase their competitiveness and sustainability.” To say it – in this exclusive interview with Il Bioeconomista – is Cyrille Pauthenier, Ceo and co-founder of Abolis, an industrial biotech company located in France. Pauthenier is graduated from École Normale Supérieure de Paris where he studied fundamental chemistry and biology. In 2011, he specialized in synthetic biology. In 2014, after obtaining his Ph.D., Cyrille co-founded Abolis, with the aim of using biology to accelerate the ecological transition of chemical industry.
“I am convinced that this crisis will teach us many lessons and I am sure that the day after will find us working together to kick-star again our economies and drive our recovery towards a more resilient, green and digital EU.” Philippe Mengal, Executive Director of BBI JU, talks to IlBioeconomista. In this exclusive interview, he tells us how the European bioeconomy is reacting to the crisis of coronavirus.
It’s awesome! The emergency is finally over. We can go back to our life. The virus was defeated without waiting for the vaccine, because we all behaved in the best way, staying at home and respecting the physical distance. Now we can go back to meet, talk to each other and, if necessary, also to hug. We’ll always remember all the dead people and the sufferings. And also the physicians and nurses and all the people who spent themselves on others.
From new models of circular economy development to technological solutions for managing and protecting resources. Ecomondo opened its doors yesterday at Rimini Expo Centre to generate Italian Exhibition Group´s vast international platform aimed at favouring the growth of an innovative entrepreneurial ecosystem, the only one able to lead to building a more sustainable future. Continue reading →